GBT - Global Blood Therapeutics Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development87,80762,16336,657
Selling General and Administrative31,43820,9649,736
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-119,245-83,127-46,393
Income from Continuing Operations
Total Other Income/Expenses Net2,22165933
Earnings Before Interest and Taxes-117,024-82,468-46,360
Interest Expense---
Income Before Tax-117,024-82,468-46,360
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-117,024-82,468-46,360
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-117,024-82,468-46,360
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-117,024-82,468-46,360